1. Mousavi SE, Ilaghi M, Hamidi
Rad R, et al. Epidemiology and
socioeconomic correlates of colorectal
cancer in Asia in 2020 and its
projection to 2040. Scientific reports.
2025;15(1):26639.
2. Zhao J, Ji H, Li K, et al. Decoding
the genetic and environmental forces
in propelling the surge of early-onset
colorectal cancer. Chinese medical
journal. 2025;138(10):1163-74.
3. Khan A, Hasana U, Nadeem IA, et
al. Advances in colorectal cancer
screening and detection: a narrative
review on biomarkers, imaging and
preventive strategies. Journal of the
Egyptian National Cancer Institute.
2025;37(1):20.
4. Fan A, Wang B, Wang X, et al.
Immunotherapy in colorectal
cancer: current achievements and
future perspective. International
journal of biological sciences.
2021;17(14):3837-49.
5. Javadi M, Jalilian S, Kanani M, et
al. Time to take HPV infection in
colorectal cancer patients more
seriously. Frontiers in Medicine.
2024;11:1418359.
6. Basnet U. Stress-Survival Pathway
Genes In Colorectal Cancer: Crc
Progression And Hispanic Disparities,
Highlighting Mcm10 As A Potential
Player: The University of Texas at El
Paso; 2025.
7. Haverkamp D, Melkonian SC,
Jim MA. Growing disparity in the
incidence of colorectal cancer among
non-Hispanic American Indian
and Alaska Native populations—
United States, 2013–2017. Cancer
Epidemiology, Biomarkers &
Prevention. 2021;30(10):1799-806.
8. Giaquinto AN, Miller KD, Tossas
KY, et al. Cancer statistics for
African American/black people 2022.
CA: a cancer journal for clinicians.
2022;72(3):202-29.
9. Fang C, Shi W, Qiao Y, et al.
Construction of a risk factor
prediction model for postoperative
complications in elderly patients
with colorectal cancer using machine
learning. Journal of Robotic Surgery.
2025;19(1):1-11.
10. Goldberg D, Pettke E, editors.
Global Perspectives on Young-Onset
Colorectal Cancer: Epidemiology,
Challenges, and Advances. Seminars
in Colon and Rectal Surgery; 2025:
Elsevier.
11. Ibrahim SM. Pathology of Colorectal
Cancer: Microscopic Analysis,
Staging, and Classification.
Advancements in Colorectal Cancer:
CRC Press. p. 9-31.
12. Prashanth K, Hanumantharayappa B.
a comprehensive review on treatment
of types of colorectal cancer. 2025.
13. Hanft W, Stankiewicz Karita
H, Khorsandi N, et al. Sexually
transmitted human papillomavirus
and related sequelae. Clinical
M i c r o b i ol o g y R e v i e w s .
2025;38(1):e00085-23.
14. Sofiani VH, Veisi P, Rukerd MRZ,
et al. The complexity of human
papilloma virus in cancers: a narrative
review. Infectious Agents and Cancer.
2023;18(1):13.
15. Schwerdt A. Value of circulating
tumor cell DNA in HPV-associated
anal carcinoma for monitoring
treatment effects and detection of
disease relapses after treatment with
definitive chemoradiation: University
of Split. School of Medicine; 2024.
16. Cosper PF, Bradley S, Luo Q, et
al. Biology of HPV mediated
carcinogenesis and tumor progression.
Seminars in radiation oncology; 2021:
Elsevier.
17. Fernandes Q, Inchakalody VP, Mestiri
S, et al. Crosstalk Between the
Oncoproteins of High‐Risk Human
Papillomaviruses Types 16 and 18
in Colorectal Cancer Cell Models.
Cancer Reports. 2025;8(6):e70197.
18. Rodolico V, Di Carlo P, Geraci G,
et al. Inflammatory Pseudotumor
of the Anal Canal Mimicking
Colorectal Cancer: Case Report and
Hints to Improve a Patient’s Fitness
for Treatment and Prevention.
Diagnostics. 2025;15(7):885.
19. Baba SK, Alblooshi SSE, Yaqoob R,
et al. Human papilloma virus (HPV)
mediated cancers: an insightful
update. Journal of Translational
Medicine. 2025;23(1):483.
20. Vats A, Trejo-Cerro O, Thomas M,
et al. Human papillomavirus E6 and
E7: What remains? Tumour virus
research. 2021;11:200213.
21. Usman M, Hameed Y, Ahmad M.
Does human papillomavirus cause
human colorectal cancer? Applying
Bradford Hill criteria postulates.
Ecancermedicalscience. 2020;14:1107.
22. Fernandes Q, Gupta I, Vranic S, et
al. Human papillomaviruses and
epstein–barr virus interactions in
colorectal cancer: A brief review.
Pathogens. 2020;9(4):300.
23. Dust K, Carpenter M, Chen JC-y, et al.
Human papillomavirus 16 E6 and E7
oncoproteins alter the abundance of
proteins associated with DNA damage
response, immune signaling and
epidermal differentiation. Viruses.
2022;14(8):1764.
24. Li J, Li S. From Viral Infection to
Genome Reshaping: The Triggering
Role of HPV Integration in Cervical
Cancer. International journal of
molecular sciences. 2025;26(18):9214.
25. Labarge B, Hennessy M, Zhang L, et
al. Human papillomavirus integration
strictly correlates with global
genome instability in head and neck
cancer. Molecular Cancer Research.
2022;20(9):1420-8.
26. Qiu Q, Li Y, Fan Z, et al. Gene
expression analysis of human
papillomavirus‐associated colorectal
carcinoma. BioMed research
international. 2020;2020(1):5201587.
27. Li Q, Geng S, Luo H, et al. Signaling
pathways involved in colorectal
cancer: pathogenesis and targeted
therapy. Signal Transduction and
Targeted Therapy. 2024;9(1):266.
28. Rad HS, Shiravand Y, Radfar P,
et al. Understanding the tumor
microenvironment in head and neck
squamous cell carcinoma. Clinical
& Translational Immunology.
2022;11(6):e1397.
29. Ambrosio MR, Niccolai E, Petrelli F,
et al. Immune landscape and oncobiota
in HPV-Associated Colorectal Cancer:
an explorative study. Clin Exp Med.
2023;23(8):5101-12.
30. Pei B, Liu P, Peng S, et al. Mendelian
randomization analyses support
causal relationships between HPV
infection and colorectal cancer.
Discover Oncology. 2024;15(1):795.
31. Pan P-H, Luo C-W, Ting W-C, et al.
Impact of ascending HPV infection on
colorectal cancer risk: evidence from
a nationwide study. Microorganisms.
2024;12(9):1746.
32. Fernandes Q, Gupta I, Murshed K, et
al. Coinfection of HPVs is associated
with advanced stage in colorectal
cancer patients from Qatar. Pathogens.
2023;12(3):424.
33. Zhou J, Liu Y, Zhang Y, et al.
Comprehensive analysis of
a novel subtype of immune
microenvironment-derived HPVinfected colorectal cancer. Microbes
and Infection. 2024;26(4):105315.
34. Thangarajah F, Busshoff J, Salamon
J, et al. Digital droplet PCR-based
quantification of ccfHPV-DNA as
liquid biopsy in HPV-driven cervical
and vulvar cancer. Journal of Cancer
Research and Clinical Oncology.
2023;149(14):12597-604.
35. Galati L, Gupta P, Tufaro A, et al. Evaluation of human papillomavirus
DNA in colorectal cancer and adjacent
mucosal tissue samples. Infectious
Agents and Cancer. 2023;18(1):71.
36. Naegele S, Ruiz-Torres DA, Zhao
Y, et al. Comparing the diagnostic
performance of quantitative PCR,
digital droplet PCR, and nextgeneration sequencing liquid biopsies
for human papillomavirus–associated
cancers. The Journal of Molecular
Diagnostics. 2024;26(3):179-90.
37. Amin FAS, Un Naher Z, Ali PSS.
Molecular markers predicting the
progression and prognosis of human
papillomavirus-induced cervical
lesions to cervical cancer. Journal
of Cancer Research and Clinical
Oncology. 2023;149(10):8077-86.
38. Athanasiou A, Bowden S, Paraskevaidi
M, et al. HPV vaccination and cancer
prevention. Best Practice & Research
Clinical Obstetrics & Gynaecology.
2020;65:109-24.
39. Kamolratanakul S, Pitisuttithum
P. Human Papillomavirus Vaccine
Efficacy and Effectiveness against
Cancer. Vaccines [Internet]. 2021;
9(12):[1413 p.].
40. Lee MY, Allen CT, editors.
Immunotherapy for HPV
malignancies. Seminars in radiation
oncology; 2021: Elsevier.
41. Mo Y, Ma J, Zhang H, et al.
Prophylactic and therapeutic HPV
vaccines: current scenario and
perspectives. Frontiers in cellular
and infection microbiology.
2022;12:909223.
42. Khairkhah N, Bolhassani A,
Najafipour R. Current and future
direction in treatment of HPV-related
cervical disease. Journal of Molecular
Medicine. 2022;100(6):829-45.
43. Huang Y, Wang J, Yang W, et al.
Precision therapeutic targets for
HPV-positive cancers: an overview
and new insights. Infectious Agents
and Cancer. 2025;20(1):17.
)